Catalog No. :	CL2138
Product Name :	Maxacalcitol (22-Oxacalcitriol)
CAS No. :	103909-75-7
Synonyms :	Maxacalcitol (22-Oxacalcitriol)
Chemical Name :	(1R,3S,Z)-5-(2-((1S,3aS,7aS,E)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
Molecular Formula :	C26H42O4
Molecular Weight :	418.61
Molecular Structure :
Appearance :	White to off-white solid
Specification :	99+%
Application :	A VDR agonist, is used in psoriasis and hyperparathyroidism research.
Registration :
Storage Condition :	4°C, protect from light, stored under nitrogen

Maxacalcitol, a vitamin D3 analog, acts as a potent orally active VDR agonist with minimal calcemic effects. It inhibits PTH mRNA expression and bone resorption, making it a promising candidate for hyperparathyroidism research. Additionally, Maxacalcitol exhibits anti-tumor activity by suppressing cell proliferation, migration, and inducing apoptosis through GPx-1 inhibition. Its unique properties suggest potential utility in treating psoriasis and underscore its significance in bone health and cancer research.

Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.